Page last updated: 2024-08-25

chitosan and Cardiometabolic Syndrome

chitosan has been researched along with Cardiometabolic Syndrome in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's3 (37.50)24.3611
2020's4 (50.00)2.80

Authors

AuthorsStudies
Tao, W; Wang, G; Wei, J1
Al-Okbi, SY; Ali, O; Aly, AS; Elbakry, HFH; Esmail, RSH; Refaat, D1
Guo, W; Li, M; Yi, L; Zhou, B1
Cao, X; Feng, B; Li, X; Yan, C; Zhang, C1
Chiang, MT; Chiu, CY; Liu, SH; Shi, CM1
Bai, Y; Du, Y; Feng, C; Jiao, S; Liu, H; Yuan, X; Zheng, J; Zheng, L1
Belcaro, G; Cesarone, MR; Cornelli, M; Cornelli, U1
Akasaki, K; Anraku, M; Kondo, Y; Maezaki, Y; Maruyama, T; Michihara, A; Nishio, H; Otagiri, M; Tomida, H; Tsuchiya, D; Yasufuku, T1

Reviews

3 review(s) available for chitosan and Cardiometabolic Syndrome

ArticleYear
The Role of Chitosan Oligosaccharide in Metabolic Syndrome: A Review of Possible Mechanisms.
    Marine drugs, 2021, Sep-01, Volume: 19, Issue:9

    Topics: Anticholesteremic Agents; Aquatic Organisms; Chitosan; Humans; Insulin Resistance; Metabolic Syndrome; Obesity; Oligosaccharides

2021
Chitosan modifies glycemic levels in people with metabolic syndrome and related disorders: meta-analysis with trial sequential analysis.
    Nutrition journal, 2020, 12-01, Volume: 19, Issue:1

    Topics: Blood Glucose; Chitosan; Glycated Hemoglobin; Humans; Insulin; Metabolic Syndrome

2020
Intestinal Population in Host with Metabolic Syndrome during Administration of Chitosan and Its Derivatives.
    Molecules (Basel, Switzerland), 2020, Dec-11, Volume: 25, Issue:24

    Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Chitosan; Cytokines; Fatty Acids; Gastrointestinal Microbiome; Humans; Hypolipidemic Agents; Inflammation; Intestines; Lipids; Metabolic Syndrome; Phosphorylation; Reactive Oxygen Species

2020

Trials

1 trial(s) available for chitosan and Cardiometabolic Syndrome

ArticleYear
Use of polyglucosamine and physical activity to reduce body weight and dyslipidemia in moderately overweight subjects.
    Minerva cardioangiologica, 2008, Volume: 56, Issue:5 Suppl

    Topics: Adult; Anticholesteremic Agents; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Chitosan; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Dyslipidemias; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Motor Activity; Overweight; Treatment Outcome; Triglycerides; Waist Circumference; Weight Loss

2008

Other Studies

4 other study(ies) available for chitosan and Cardiometabolic Syndrome

ArticleYear
Management of metabolic syndrome by nutraceuticals prepared from chitosan and ferulic acid with or without beta-sitosterol and their nanoforms.
    Scientific reports, 2023, 07-27, Volume: 13, Issue:1

    Topics: Animals; Atorvastatin; Chitosan; Diet, High-Fat; Dietary Supplements; Fructose; Insulin Resistance; Metabolic Syndrome; Rats

2023
Functional Comparison of High and Low Molecular Weight Chitosan on Lipid Metabolism and Signals in High-Fat Diet-Fed Rats.
    Marine drugs, 2018, Jul-29, Volume: 16, Issue:8

    Topics: Animals; Anticholesteremic Agents; Blood Glucose; Chitosan; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Lipid Metabolism; Lipids; Lipogenesis; Liver; Male; Metabolic Syndrome; Molecular Weight; Oxidation-Reduction; Rats; Rats, Sprague-Dawley

2018
Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARĪ³).
    Marine drugs, 2018, Nov-19, Volume: 16, Issue:11

    Topics: Animals; Chitosan; Cytokines; Diet, High-Fat; Disease Models, Animal; Glycolipids; Hep G2 Cells; Humans; Inflammation Mediators; Lipid Metabolism; Liver; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Oligosaccharides; PPAR gamma; Treatment Outcome; Up-Regulation

2018
The antioxidative and antilipidemic effects of different molecular weight chitosans in metabolic syndrome model rats.
    Biological & pharmaceutical bulletin, 2010, Volume: 33, Issue:12

    Topics: Albumins; Animals; Antioxidants; Blood Glucose; Body Weight; Chitosan; Cholesterol; Cholesterol, LDL; Creatinine; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Free Radicals; Gastrointestinal Tract; Hypolipidemic Agents; Male; Metabolic Syndrome; Molecular Weight; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Reference Values; Triglycerides

2010